SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-16-000239
Filing Date
2016-11-28
Accepted
2016-11-28 16:02:57
Documents
4
Period of Report
2016-11-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a201611228-kdoccn.htm 8-K 44206
2 EXHIBIT 4.1 a201611228-kcnex41.htm EX-4.1 494651
3 EXHIBIT 4.2 a201611228-kcnex42.htm EX-4.2 540615
4 EXHIBIT 4.3 a201611228-kcnex43.htm EX-4.3 53228
  Complete submission text file 0000882104-16-000239.txt   1134049
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 162019950
SIC: 2836 Biological Products, (No Diagnostic Substances)